News Archives | Future Medicine India


Lung cancer incidences increase in women, say experts at Neuberg Centre for Genomic Medicine

The number of lung cancer incidences are on the rise among women, said lung cancer experts at Neuberg Centre for Genomic Medicine Panel discussion on 'Lung Cancer Detection – How Late, is Late?'.

Read More..

Microplasma may help treat middle-ear infections: Study

In a new study, researchers at the University of Illinois at Urbana-Champaign explored the use of microplasma — a highly focused stream of chemically excited ions and molecules —  for attacking the bacterial biofilms that resist antibiotic treatment in the middle ear. Their findings were published  in the journal npj Biofilms and Microbiome


FDA approves first interchangeable biosimilar insulin for treating diabetes

The U.S. Food and Drug Administration approved the first interchangeable biosimilar insulin product to improve glycemic control in adults and pediatric patients with Type 1 diabetes mellitus and in adults with Type 2 diabetes mellitus.


Study finds telmisartan use reduces dementia risk in hypertensive and diabetes patients

A study based in Taiwan found that administering telmisartan, a medication used to treat high blood pressure, heart failure, and diabetic kidney disease reduces the risk of dementia and ischemic stroke in hypertensive (HT) patients with type 2 diabetes mellitus (T2DM).


USFDA approves pembrolizumab for triple-negative breast cancer treatment

The U.S. Food and Drug Administration (USFDA) has approved the immunotherapy drug pembrolizumab (Keytruda) as a treatment for patients with high-risk early-stage triple-negative breast cancer (TNBC) in combination with chemotherapy, announced the pharmaceutical company Merck & Co Inc.


Research shows suboptimal response to COVID-19 vaccines in blood cancer patients

A study conducted by researchers in Egypt has found that multiple myeloma patients mount variable and sometimes suboptimal responses after receiving the Pfizer-BioNTech or Moderna COVID-19 vaccines.


Eye tests could help identify patients suffering from long Covid

Signs of nerve damage in the cells of the surface of the eyes can help identify patients likely to suffer from ‘long Covid’, according to a new study conducted by researchers from Turkey and Qatar. The study was  published in the British Journal of Ophthalmology.